Actively Recruiting
Aeson TAH System - Post-Market Clinical Follow-up Study
Led by Carmat SAS · Updated on 2026-01-28
95
Participants Needed
1
Research Sites
440 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The safety and performance of the Aeson TAH system have been demonstrated for the CE mark approval in December 2020. The purpose of this post-market clinical investigation is to confirm the safety, performance and effectiveness of the Aeson TAH system when used in routine care by surgeons.
CONDITIONS
Official Title
Aeson TAH System - Post-Market Clinical Follow-up Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is intended to receive an Aeson TAH system according to the IFU indications within standard medical practice
- Patient has provided written informed consent using the Ethics Committee approved consent form
You will not qualify if you...
- Vulnerable populations who could not voluntarily consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HZ Dresden
Dresden, Germany, 01307
Actively Recruiting
Research Team
E
Elisabeth Vacher
CONTACT
P
Piet Jansen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here